Table 1 Outcomes used in DLB clinical trials
From: Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations
Domain | Assessed in clinical trials: n (%) | Primary outcome: n (%) | Most common method used (n) |
|---|---|---|---|
Functional | 22 (52) | 5 (11) | ZBI (7) |
Cognitive | 39 (92) | 17 (40) | MMSE (33) |
Visual hallucinations | 35 (83) | 21 (50) | NPI (22) |
Fluctuations | 9 (21) | 1 (2) | Mayo FSI (4) |
Motor | 28 (66) | 10 (23) | UPDRS-III (23) |
RBD | 1(2) | 1 (2) | RBDSS scale (1) |